Top Markets
Coin of the day
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
Rank in Stocks #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
Share Price
$0.94
Last synced: 2025-02-28
Market Cap
$2.73M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Fresh Tracks Therapeutics, Inc. (FRTX)

Category

Stock price history for Fresh Tracks Therapeutics, Inc. (FRTX)
Highest end of day price: $0.93 on 2025-02-01

Lowest end of day price: $17.60K on 1993-03-01
Stock price history of Fresh Tracks Therapeutics, Inc. from 1993 to 2026
Annual Stock Price Performance
Year Performance
2025 25.41%
2024 -12.67%
2023 -44.20%
2022 -87.64%
2021 -62.29%
2020 -56.41%
2019 -79.67%
2018 -35.82%
2017 -21.99%
2016 -41.65%
2015 -62.32%
2014 -5.40%
2013 -62.56%
2012 -33.38%
2011 129.70%
2010 -33.25%
2009 132.91%
2008 -71.15%
2007 -34.72%
2006 40.95%
2005 4.97%
2004 -6.60%
2003 35.73%
2002 -70.26%
2001 -36.17%
2000 -14.37%
1999 47.84%
1998 16.60%
1997 -25.73%
1996 63.98%
1995 35.35%
1994 -42.99%
1993 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE